{
  "claim_id": "claim_001",
  "claim": "Flublok contains 3x the hemagglutinin (HA) antigen content of standard-dose flu vaccines, which has been linked to greater immunogenicity vs standard-dose flu vaccines.",
  "document": {
    "pdf_name": "FlublokPI",
    "source_pdf": "data/clinical_files/FlublokPI.pdf",
    "total_pages": 5,
    "total_blocks": 72
  },
  "extraction_result": {
    "success": true,
    "total_snippets_found": 3,
    "error": null
  },
  "supporting_snippets": [
    {
      "id": 1,
      "quote": "Each 0.5 mL dose of Flublok contains 45 mcg HA of each of the following 3 influenza virus strains",
      "relevance_explanation": "This quote specifies the hemagglutinin (HA) antigen content per strain in Flublok, which is 45 mcg per strain."
    },
    {
      "id": 2,
      "quote": "Flublok is standardized according to United States Public Health Service (USPHS) requirements for the 2024-2025 influenza season and contains 135 mcg of recombinant hemagglutinin (HA) per 0.5 mL dose, with 45 mcg HA of each of the following 3 influenza virus strains",
      "relevance_explanation": "This quote confirms the total HA content in Flublok (135 mcg per dose, 45 mcg per strain), which is three times the standard 15 mcg per strain in standard-dose flu vaccines."
    },
    {
      "id": 3,
      "quote": "Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccines (TIVs) among persons \u226565 years old. Vaccine. 2009, Vol. 28, pp. 379-385.",
      "relevance_explanation": "This reference to a clinical study directly compares the immunogenicity of Flublok (which contains 3x the HA content) to standard-dose inactivated vaccines, supporting the claim that higher HA content is linked to greater immunogenicity."
    }
  ],
  "model_used": "gpt-4.1"
}